Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus

Silent Myocardial Infarction and Hypoglycaemia

(2010) Hsin K. Goh et al.   ENDOCRINOLOGIST

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes

(2009) J. Rosenstock et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone

(2009) R. A. DeFronzo et al.   DIABETES CARE

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

(2009) M. Jadzinsky et al.   DIABETES OBESITY & METABOLISM

Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial

(2009) A. Schweizer et al.   DIABETES OBESITY & METABOLISM

Global estimates of the prevalence of diabetes for 2010 and 2030

(2009) J.E. Shaw et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Saxagliptin

(2009) Sohita Dhillon et al.   DRUGS

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

(2009) A. R. Chacra et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone

(2009) Priscilla Hollander et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Key priorities in managing glucose control in older people with diabetes

(2009) Isabelle Bourdel-Marchasson et al.   Journal of Nutrition Health & Aging

Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies

(2009) Richard E. Pratley et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Risk factors and management of diabetes in elderly French patients

(2008) J. Doucet et al.   DIABETES & METABOLISM

Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes

(2008) J. Rosenstock et al.   DIABETES OBESITY & METABOLISM

New Approaches to Treating Type 2 Diabetes Mellitus in the Elderly

(2008) Angela M Abbatecola et al.   DRUGS & AGING